Therapeutics Company Acquires Biotech Firm To Combat Global Health Threats

In an announcement that could potentially reshape the landscape of biodefense and public health, Aditxt, Inc. has revealed a definitive agreement to acquire Appili Therapeutics Inc., marking a significant step in the fight against global health threats. This acquisition not only underscores the importance of innovative solutions in addressing complex health challenges but also highlights the strategic moves by biotech firms to bolster their portfolios with cutting-edge technologies and products. $Aditxt(ADTX.US)$